a vaccine originally developed for Zaire ebolavirus is being considered for use against the Bundibugyo species, despite no design basis for this application
Up to 12 framings across outlets and orientations — each a short phrase the extractor generated to characterise the piece's editorial angle (not a quote). Filter by lean to see how each bloc is spinning the story; click through to read the original.
scientific uncertainty about cross-species efficacy
Can a vaccine built for one Ebola virus stop another? The World Health Organization is about to find outStacked weekly counts; colour by lean. “n/a” covers government and iwi-Māori sources where lean isn't applicable.
How this topic has been named, week by week. A new alias winning out is usually a framing shift.
Spotted something wrong on this page? Report a correction.